Chardan Healthcare Acquisition Corp.
SEC CIK 1739174 · PHGE] · last insider filing 2026-03-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Yeganeh Reuven | Director | filed 2026 - 2026 |
| Bidas Liat Cohavi | Director | filed 2026 - 2026 |
| Deerfield Management Company, L.P. (Series C) | Director | filed 2024 - 2025 |
| Flynn James E | Director | filed 2024 - 2025 |
| Deerfield Mgmt HIF, L.P. | Director | filed 2024 - 2025 |
| Deerfield Healthcare Innovations Fund II, L.P. | Director | filed 2024 - 2025 |
| Deerfield Private Design Fund V, L.P. | Director | filed 2024 - 2025 |
| Deerfield Mgmt V, L.P. | Director | filed 2024 - 2025 |
| Leff Jonathan S | Director | filed 2024 - 2025 |
| Williams Eddie | Director | filed 2023 - 2025 |
| Goodman Jesse | Director | filed 2024 - 2025 |
| Greig Russell | Director | filed 2019 - 2025 |
| Blum Susan | Director | filed 2024 - 2025 |
| Solomon Jonathan Eitan | Director · Chief Executive Officer | filed 2019 - 2025 |
| Moses Alan Charles | Director | filed 2020 - 2025 |
| Merril Gregory Louis | Director | filed 2024 - 2025 |
| Orbimed Israel GP Ltd. | Director | filed 2019 - 2024 |
| Orbimed Israel Biofund GP Limited Partnership | Director | filed 2019 - 2024 |
| Chimovits Erez | Director | filed 2019 - 2024 |
| Deerfield Mgmt HIF II, L.P. | Director | filed 2024 - 2024 |
| Marks Jason M. | Director | filed 2023 - 2023 |
| Dambach Michael E. | Director | filed 2023 - 2023 |
| Sullivan Lynne Marie | Director | filed 2019 - 2023 |
| Grossman Jonas | Director · President, CEO and Director | filed 2018 - 2022 |
| Amusa Gbolahan | Director · Executive Chairman | filed 2018 - 2022 |
| Sekhri Paul J | Director | filed 2020 - 2021 |
| Breski Yaron | Director | filed 2019 - 2020 |
| Ben-Or Uri | Director | filed 2019 - 2019 |
| Woodman Robbie | Director | filed 2019 - 2019 |
| Gnedy Elliot | Director | filed 2018 - 2018 |
| Rice Yehuda Michael | Director | filed 2018 - 2018 |
| Giroux Richard | Director | filed 2018 - 2018 |
| Kaufman George | Director · CFO & HOS & Director | filed 2018 - 2018 |
| Kusseluk Eric | Director | filed 2018 - 2018 |
| Rossen Matthew | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bassan Merav | Chief Development Officer | filed 2019 - 2025 |
| Wolfson Marina | SVP of Finance & Operations | filed 2020 - 2025 |
| Oron Assaf | Chief Business Officer | filed 2019 - 2024 |
| Gabay Avraham | Interim CFO | filed 2023 - 2023 |
| Puttagunta Sailaja | Chief Medical Officer | filed 2019 - 2021 |
| Golembo Myriam | Vice President of Development | filed 2019 - 2019 |
| Gahali-Sass Inbar | VP of Platform Research&Devel. | filed 2019 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.